Solazyme and Unilever Sign Commercial Supply Agreement for Tailored Algal Oil

  Solazyme and Unilever Sign Commercial Supply Agreement for Tailored Algal
  Oil

   Unilever further commits to lead in global sustainability initiatives by
 sourcing Solazyme Tailored Algal Oil from the Solazyme Bunge Renewable Oils
                                    plant

Business Wire

SOUTH SAN FRANCISCO, Calif. -- September 25, 2013

Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, and
Unilever, one of the world’s leading consumer goods companies, announced today
that they have executed a commercial supply agreement for the first partnered
Solazyme Tailored™ Algal Oil. The companies have been collaborating for five
years on multiple projects with increasing levels of success culminating in
this initial supply agreement. The agreement covers the first of Solazyme and
Unilever’s jointly developed tailored oils with an initial supply of at least
10,000 metric tons (MT). The oil will be produced at the Solazyme Bunge
Renewable Oils facility, a joint venture of Solazyme and Bunge located at
Bunge’s Moema sugar mill in Brazil. Supply delivery is planned to begin in
early 2014 and Unilever expects to purchase the full volume within twelve to
eighteen months. Customary product validation trials are scheduled to take
place in Q4 2013.

“Unilever is a global leader in both performance based consumer packaged goods
and sustainability, and this agreement further solidifies their commitment to
supply consumers with the best performing and most sustainable products
available,” said Jonathan Wolfson, CEO, Solazyme. “Unilever is a highly valued
strategic partner that has greatly influenced our ability to scale our
tailored oil technology over the past several years. We look forward to the
opportunity to continue to build and expand our relationship with Unilever as
we take this next step in commercializing the world’s first tailored renewable
oil production platform. We expect this to be the first of many supply
agreements with Unilever.”

“This first supply agreement is the result of many years of successful
collaboration, during which Solazyme demonstrated strength as a partner and
continually achieved key development milestones outlined by our world-class
scientific and technology teams,” said David Blanchard, Chief Category R&D
Officer, Unilever. “We believe that Solazyme’s tailored oils technology can
provide sustainable competitive advantage across many categories and brands,
and we view this agreement as just the beginning of the commercial phase of
our relationship.”

AboutSolazyme, Inc.

Solazyme, Inc.(SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost plant-based sugars into high-value oils and
food ingredients. Headquartered inSouth San Francisco,Solazyme'srenewable
products can replace or enhance oils derived from the world's three existing
sources — petroleum, plants and animal fats. Initially,Solazymeis focused on
commercializing its products into three target markets: (1) chemicals and
fuels, (2) nutrition and (3) skin and personal care.

Solazyme®, theSolazymelogo and other trademarks or service names are
trademarks ofSolazyme, Inc.

About Unilever

Unilever is one of the world’s leading suppliers of Food, Home and Personal
Care products with sales in over 190 countries. Our products are present in 7
out of 10 homes globally and are used by over 2 billion people on a daily
basis. We work with 173,000 colleagues around the world and generated annual
sales of over €50 billion in 2012. Over half of our company’s footprint is in
the faster growing developing and emerging markets (57% in Q1 2013). Working
to create a better future every day, we help people feel good, look good and
get more out of life. Our portfolio includes some of the world’s best known
brands such as Knorr, Persil / Omo, Dove, Sunsilk, Hellmann’s, Lipton, Rexona
/ Sure, Wall’s, Lux, Rama, Ponds and Axe, 14 of which now generate a turnover
of €1 billion or more.

Our ambition is to double the size of our business, whilst reducing our
overall environmental footprint (including sourcing, consumer use and
disposal) and increasing our positive social impact. We are committed to
helping more than a billion people take action to improve their health and
well-being, sourcing all our agricultural raw materials sustainably by 2020,
and decoupling our growth from our environmental impact. Supporting our three
big goals, we have defined seven pillars, underpinned by targets encompassing
social, environmental and economic areas. See more on the Unilever Sustainable
Living Plan at www.unilever.com/sustainable-living/.

Unilever has been recognised in the Dow Jones Sustainability World Indexes for
14 consecutive years. We are included in the FTSE4Good Index Series and
attained a top environmental score of 5, leading to inclusion in the FTSE4Good
Environmental Leaders Europe 40 Index. In 2012 Unilever led the Climate Counts
Company Scorecard and the list of Global Corporate Sustainability Leaders in
the GlobeScan /Sustainability latest annual survey - both for the third year
running. The company is an employer of choice in many of the countries in
which it operates and is seen as a symbol for innovation and leadership
development. For more information about Unilever and its brands, please visit
www.unilever.com.

Forward Looking Statements

This press release contains certain forward-looking statements about Solazyme,
including statements that involve risks and uncertainties concerning: the
timing of supply and delivery; the volume of supply; potential uses of the
oils; the ability to launch successful products using Solazyme’s oils; market
demand for such products; the timetable for bringing facilities online and
manufacturing products; the ability to bring manufacturing facilities online
with partners; development of additional products; meeting commercialization
and technology targets and other objectives; and Solazyme’s ability to
maintain its relationships with its partners. When used in this press release,
the words “will”, “expects”, “intends” and other similar expressions and any
other statements that are not historical facts are intended to identify those
assertions as forward-looking statements. Any such statement may be influenced
by a variety of factors, many of which are beyond the control of Solazyme,
that could cause actual outcomes and results to be materially different from
those projected, described, expressed or implied in this press release due to
a number of risks and uncertainties. Potential risks and uncertainties
include, among others: Solazyme’s limited operating history; its limited
history in commercializing products; successful completion of validation
trials; implementation risk in deploying new technologies; its limited
experience in constructing and operating commercial manufacturing facilities;
market acceptance of its products; entry into additional supply agreements;
delays related to construction, start-up or funding of production facilities;
its access to adequate supply of feedstock on favorable terms; its ability to
manage operational costs at production facilities; its ability to enter into
and maintain strategic collaborations, including the funding thereof; its
ability to obtain requisite regulatory and other approvals; its ability to
manage costs and expenses; and its access, on favorable terms, to any required
financing. Accordingly, no assurances can be given that any of the events
anticipated by the forward-looking statements will transpire or occur, or if
any of them do so, what impact they will have on the results of operations or
financial condition of Solazyme.

In addition, please refer to the documents that Solazyme, Inc. files with the
Securities and Exchange Commission, including its Quarterly Reports on Form
10-Q for a discussion of these and other risks. You are cautioned not to place
undue reliance on forward-looking statements, which speak only as of the date
of this press release. Solazyme is not under any duty to update any of the
information in this press release.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130924007003/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50715958&lang=en

Contact:

Solazyme, Inc.
Genet Garamendi, 650-780-4777
VP of Corporate Communications
Press@solazyme.com
or
Brainerd Communicators, Inc.
Jeff Majtyka, 212-986-6667
majtyka@braincomm.com
Brad Edwards, 212-986-6667
edwards@braincomm.com
 
Press spacebar to pause and continue. Press esc to stop.